Catalyst Wire Dossier Catalyst Wire Dossier

LAS 41002

· Almirall, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAS 41002, covering 2010-07-12 to 2010-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema [Phase 2]

See pricing